Adequacy of anticoagulation in patients with atrial fibrillation coming to a hospital

被引:48
作者
Bungard, TJ
Ackman, ML
Ho, G
Tsuyuki, RT
机构
[1] Univ Alberta, Div Cardiol, Edmonton, AB T6G 2S2, Canada
[2] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB T6G 2S2, Canada
来源
PHARMACOTHERAPY | 2000年 / 20卷 / 09期
关键词
D O I
10.1592/phco.20.13.1060.35038
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Study Objective. To evaluate the adequacy of anticoagulation in patients with atrial fibrillation (AF) coming to a hospital. Design. Retrospective medical record review Setting. Tertiary care hospital. Patients. Consecutive patients with a history of AF who had been prescribed warfarin and who had the international normalized ratio (INR) measured when they arrived at the hospital. Those who developed AF as a complication during hospitalization were excluded. Measurements and Main Results. Of 1085 patients, 375 (mean age 73 yrs, 56.3% men) were eligible for further evaluation. Most had nonvalvular AF; in 44.5% the INR was subtherapeutic, in 36.5% it was therapeutic, and in 18.9% it was supratherapeutic. Patients admitted for any thromboembolic event and for ischemic stroke were significantly more likely to have subtherapeutic INRs. Conclusion. It is well documented in the literature that warfarin is underprescribed, but our results suggest that even in treated patients, about half are inadequately protected from thromboembolism.
引用
收藏
页码:1060 / 1065
页数:6
相关论文
共 30 条
[1]   STROKE PREVENTION IN NONVALVULAR ATRIAL-FIBRILLATION [J].
ALBERS, GW ;
ATWOOD, JE ;
HIRSH, J ;
SHERMAN, DG ;
HUGHES, RA ;
CONNOLLY, SJ .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (09) :727-736
[2]   Clinical characteristics and management of acute stroke in patients with atrial fibrillation admitted to US university hospitals [J].
Albers, GW ;
Bittar, N ;
Young, L ;
Hattemer, CR ;
Gandhi, AJ ;
Kemp, SM ;
Hall, EA ;
Morton, DJ ;
Yim, J ;
Vlasses, PH .
NEUROLOGY, 1997, 48 (06) :1598-1604
[3]  
ASINGER RW, 1989, ARCH NEUROL-CHICAGO, V46, P727
[4]   Warfarin use among patients with atrial fibrillation [J].
Brass, LM ;
Krumholz, HM ;
Scinto, JM ;
Radford, M .
STROKE, 1997, 28 (12) :2382-2389
[5]   Why do patients with atrial fibrillation not receive warfarin? [J].
Bungard, TJ ;
Ghali, WA ;
Teo, KK ;
McAlister, FA ;
Tsuyuki, RT .
ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (01) :41-46
[6]   ANTICOAGULATION CLINICS AND THE MONITORING OF ANTICOAGULANT-THERAPY [J].
CHARNEY, R ;
LEDDOMADO, E ;
ROSE, DN ;
FUSTER, V .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 1988, 18 (02) :197-206
[7]   Comparison of an anticoagulation clinic with usual medical care -: Anticoagulation control, patient outcomes, and health care costs [J].
Chiquette, E ;
Amato, MG ;
Bussey, HI .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (15) :1641-1647
[8]   CANADIAN ATRIAL-FIBRILLATION ANTICOAGULATION (CAFA) STUDY [J].
CONNOLLY, SJ ;
LAUPACIS, A ;
GENT, M ;
ROBERTS, RS ;
CAIRNS, JA ;
JOYNER, C .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (02) :349-355
[9]   9-YEAR EXPERIENCE WITH A PHARMACIST-MANAGED ANTICOAGULATION CLINIC [J].
CONTE, RR ;
KEHOE, WA ;
NIELSON, N ;
LODHIA, H .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1986, 43 (10) :2460-2464
[10]  
CORTELAZZO S, 1993, THROMB HAEMOSTASIS, V69, P316